Log In
Print this Print this

BioChaperone insulin combo (BioChaperone Combo)

  Manage Alerts
Collapse Summary General Information
Company Adocia S.A.
DescriptionCombination of long-acting insulin glargine (75%) and fast-acting insulin lispro (25%) using BioChaperone polymer technology
Molecular Target Insulin receptor (INSR)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes; Treat Type I and Type II diabetes; Treat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today